Where does Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. ranks #35,866 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. hold?

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. holds 7 US utility patents granted between 2017 and 2025, spanning 6 technology areas.

What is Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s Innovation Score?

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. has an Innovation Score of 37.3 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s patent grant rate increasing or decreasing?

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s patents?

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s patents average 13.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.

Q: What technology areas does Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. focus on?

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s top technology area is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture) with 6 patents, ranking #307 of 1,268 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Q: How is the Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inner ranks #35,866 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.

#35,866
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.3/100): 13.6
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35866 · Foreign Corporation #35,866 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,866/49,997
PHOTO-FINISH Indicator Systems…
CPC-NARROW C12P · 6 areas
INNOV-THIN 37.3/100
CLAIMS-RICH 13.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Indicator Systems International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inner’s 37.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (19%) Velocity 13.3 pts (36%) Breadth 8.7 pts (23%) Claim depth 8.1 pts (22%)

Qualcomm Incorporated · highest

85
Inner Mongolia… · this assignee

37
3D Lighting… · lowest

7

What this shows Inner's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Inner?

Each dot is one of Inner’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inner’s own 13.6 claims/patent is ABOVE the 9.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Inner vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inner's grants concentrate

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 85.7% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2017. By volume, Inner sits between Indicator Systems International, Inc. and Innovation Thru Energy Co Ltd..

Inner's three-year grant acceleration

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Indicator Systems…

7
Industries RAD

7
Ineos Automotive

7
Infrastructure Pr…

7
Innodep

7
Innogel

7
Innopeak Technolo…

7
Innovation Thru E…

7
Inner Mongolia Ki… ◀

7

What this shows Inner holds 7 patents at rank #35,819, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inner

By rank, the assignees closest to #35,819 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Inner's primary technology class.

Inner's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2018	1	14.3%
2023	2	28.6%
2025partial year	3	42.9%

Which technologies does Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. patent most?

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Y - Enzymes 1

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 85.7% of its portfolio - see every assignee active in that class. Explore C12P
Ranked #35,866 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. against Indicator Systems International, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.